PARK7 and Alzheimer disease: Its anti-AD molecular mechanisms involve alleviating Aβ deposition, neuronal loss, synaptic loss and iron accumulation by regulating the DJ-1/Nrf2 signaling pathway in AD mice (Long et al., 2024).